Q3 2025 revenue and adjusted EPS* above the high end of our guidance ranges; Raising 2025 annual outlookTORONTO, Oct. 27, ...

Q3 2025 Earnings Call Transcript October 27, 2025 BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS ...

Celestica Inc.1 (NYSE: CLS) (TSX: CLS), a global leader in data center infrastructure and advanced technology solutions, today announced its financial results ...

On August 28, 2025, the NXP board of directors has approved the payment of an interim dividend of $1.014 per ordinary share for the third quarter of 2025. The interim dividend was paid in cash on ...

Q3 2025 Sales Call October 30, 2025 4:00 AM EDTCompany ParticipantsCraig Marks - Head of Investor RelationsRichard Saynor ...

FFO, as adjusted was $149.0 million for the third quarter of 2025 compared with $153.0 million for the third quarter of 2024. FFO, as adjusted, per diluted share decreased 3.0% to $0.65 for the third ...

CHARLOTTE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- SPX Technologies, Inc. (NYSE:SPXC) ("SPX”, the "Company”, "we” or "our”) today reported results for the third quarter ended September 27, 2025.

NXP Semiconductors N.V. (NASDAQ: NXPI) today reported financial results for the third quarter, which ended September 28, 2025. "NXP reported ...

Agentic features open the door to data exfiltration or worse Feature With great power comes great vulnerability. Several new AI browsers, including OpenAI's Atlas, offer the ability to take actions on ...

For the third quarter of 2025, GAAP results include a net charge of $164 million, or $0.19 per diluted share, comprised of ...

FISCAL 2025 Q4 HIGHLIGHTS Net sales of $978.2 million increased 2.7% YoY Operating income of $84.3 million, or $90.3 million on an adjusted basis1 Operating margin of 8.6%, or 9.2% on an adjusted ...